|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Operating expenses: | ||||
| Research and development | ||||
| General and administrative | ||||
| Restructuring charges | ||||
| Total operating expenses | ||||
| Loss from operations | ||||
| Interest income | ||||
| Other income | ||||
| Net loss | ||||
| Net loss attributable to common stockholders | ||||
| Net loss per share attributable to common stockholders, basic | ||||
| Net loss per share attributable to common stockholders, diluted | ||||
| Weighted-average number of shares used in computing net loss per share, basic | ||||
| Weighted-average number of shares used in computing net loss per share, diluted | ||||
| Other comprehensive loss: | ||||
| Unrealized gain (loss) on investments | ||||
| Comprehensive loss | ||||
Loading...